Development of a conditional T1MP-1 knockout mouse
Development of a conditional T1MP-1 knockout mouse
批准号:
8283645
负责人:
Stephen J Crocker
金额:
$7.7万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31
关键词:
ApoptoticAreaAstrocytesBacterial InfectionsBirth WeightBrainBrain InjuriesCellsCentral Nervous System DiseasesConfounding Factors (Epidemiology)DemyelinationsDevelopmentDiseaseDisease modelEnzymesExonsExtracellular ProteinFamilyFunctional RNAGene ExpressionGenerationsGenesGenetic RecombinationGlial Fibrillary Acidic ProteinHomeostasisImmuneImmunologyInflammationInflammatoryInjuryInterleukinsIntronsKnock-outKnockout MiceLitter SizeMalignant NeoplasmsMatrix MetalloproteinasesMediatingMessenger RNAMetalloproteinase GeneMicrogliaMouse StrainsMusNeuronsNeurosciencesOligodendrogliaPhysiologicalPlayProceduresProductionProteinsReagentRecoveryRegulationReportingResearchResearch Project GrantsRoleSiteSourceSpinal CordSynaptic plasticityT-LymphocyteTechnologyTestingTissue Inhibitor of Metalloproteinase-1TissuesTransgenic MiceValidationWeight GainWorkX Chromosomeanticancer researchbehavior influencebrain tissuecell typecentral nervous system injurycytokinedesignextracellularmacrophagenervous system disorderneuropathologyneuroprotectionpromoterrecombinaseresponsetumorigenesisvectorvirology
中文摘要
描述(由申请人提供):组织金属蛋白酶抑制剂-1 (TIMP-1)是一种多营养细胞外蛋白,在炎症或损伤后在大脑中显著上调。TIMP-1作为基质金属蛋白酶(MMPs)蛋白水解活性的内源性调节剂具有良好的功能,基质金属蛋白酶(MMPs)是细胞外酶家族,在细胞稳态、适应和组织重塑中起关键作用。TIMP-1还具有与mmp无关的功能,包括抗凋亡活性和营养作用。TIMP-1的后一种功能与突触可塑性、神经保护、肿瘤发生和少突胶质细胞分化有关。TIMP-1可以在中枢神经系统的多种细胞类型中表达:星形胶质细胞在中枢神经系统炎症脱髓鞘或细菌感染时强烈表达TIMP-1,神经元在兴奋性毒性损伤后表达TIMP-1。在中枢神经系统损伤和炎症过程中,还需要指出的是,TIMP-1也通过免疫细胞表达,包括T细胞、巨噬细胞和小胶质细胞。因此,TIMP-1可以在多种细胞类型中快速表达,这为TIMP-1在中枢神经系统损伤或疾病反应中提供了无数的潜在作用。目前,只有全球的TIMP-1KO小鼠可用于研究,这意味着TIMP-1的细胞来源仍然是我们理解TIMP-1在大脑中的具体机制作用的一个混杂变量。测试特定细胞类型产生的TIMP-1是否有差异影响
英文摘要
DESCRIPTION (provided by applicant): Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a pleiotrophic extracellular protein that is dramatically upregulated in the brain following inflammation or injury. TIMP-1 has a well described function as an endogenous regulator of the proteolytic activities of the matrix metalloproteinases (MMPs) a family of extracellular enzymes that play critical roles in cellular homeostasis, adaptation and tissue remodeling. TIMP-1 also has noted MMP-independent functions including antiapoptotic activity and trophic actions. These latter functions of TIMP-1 have been implicated in synaptic plasticity, neuroprotection, oncogenesis and oligodendrocyte differentiation. TIMP-1 can be expressed by a variety of cell types in the CNS: astrocytes robustly express TIMP-1 in response to inflammatory demyelination or bacterial infection in the CNS, and neurons have been reported to express TIMP-1 following excitotoxic injury. In the course of CNS injury and inflammation, it is also important to point out that TIMP-1 is also expressed by immune cells, including T cells, macrophages and microglia. Thus, TIMP-1 can be rapidly expressed by a variety of cell types offering a myriad of potential roles for TIMP-1 in response to CNS injury or disease. Currently, only global TIMP-1KO mice are available for study meaning that the cellular source of TIMP-1 remains a confounding variable to our understanding on the specific mechanistic roles of TIMP-1 in the brain. To test whether production of TIMP-1 from specific cell types differentially impact
neuropathology, we will develop an essential new reagent: a conditional TIMP-1 knockout mouse (TIMP-1cKO) line. This mouse line will significantly advance our understanding of TIMP-1 and its functions in the CNS by enabling us to directly test whether cell specific-TIMP-1 expression impacts the innate potential for brain recovery following injury. The first aim of this proposal will be to develop the new TIMP-1cKO mouse, which will then be crossed with the GFAP-Cre transgenic mouse to specifically knockout TIMP-1 expression from astrocytes throughout the CNS. Astrocyte-specific TIMP-1cKO mice will then be tested and compared with global. Together this work will, (a) provide a valuable new reagent for advanced study on TIMP-1 in a wide variety of disease models, including neurological diseases, and, (b) experimental results from this work will validate the TIMP-1cKO mouse as a viable new mouse line for study of cell-specific deletion of TIMP-1.
PUBLIC HEALTH RELEVANCE: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a protein that can protect the brain from injury and disease in a variety of ways. The purpose of this research project is to develop a new mouse strain where this protein can be eliminated from specific cells, and in so doing allow us to better understand how TIMP-1 can influence the behaviour of different types of cells during disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of CD8 T cell-mediated Pathology in Globoid Cell Leukodystrophy
-
批准号:10634808
-
项目类别:
-
资助金额:$51.91万
-
财政年份:2023
-
负责人:Stephen J Crocker
-
依托单位:
The Contribution of Central Nervous System Demyelination to Bladder Dysfuntion
-
批准号:10352892
-
项目类别:
-
资助金额:$45.1万
-
财政年份:2021
-
负责人:Stephen J Crocker
-
依托单位:
Proteomic and Functional Analyses of Astrocyte Exosomes
-
批准号:8893411
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2015
-
负责人:Stephen J Crocker
-
依托单位:
Development of a conditional T1MP-1 knockout mouse
-
批准号:8417649
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2012
-
负责人:Stephen J Crocker
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: